T22 "Correspondence"

Email correspondence, letters, faxes and press releases relating to C0168T22 study. Includes correspondence relating to drafts of paper "The Relationship of Serum Infliximab Concentrations to Clinical Improvement in Rheumatoid Arthritis," results from the study, researcher interest in the study, adverse reactions and study data. The correspondence also relates to the discussion/decision to unblind placebo patients after study results showed positive results.

File also contains guidelines for the use of Remicade/Infliximab (cA2), correspondence relating to ongoing treatment of Infliximab post study, study steering committee minutes and study patient reports.

1996-2001

1 file (in 2 parts)

This item requires facilitated access. Email library@wellcomecollection.org to request an appointment.